Published in Exp Hematol on November 01, 1995
Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis. PLoS One (2012) 0.89
T lymphocytes from granulocyte colony-stimulating factor-/- mice produce large quantities of interferon-gamma in a chronic infection model. Immunology (2000) 0.81
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model. Biologics (2009) 0.78
Granulocyte colony-stimulating factor administration and monocyte phenotype. Exp Hematol (1996) 0.75
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med (1993) 2.90
Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol (2006) 2.79
Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol (1980) 2.15
Use of quantitative bacteriologic techniques to diagnose catheter-related sepsis. Arch Intern Med (1979) 2.06
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Changes in serum colony-stimulating factor and monocytic progenitor cells during Listeria monocytogenes infection in mice. Infect Immun (1984) 1.70
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
Prevention of Legionella infections in a bone marrow transplant unit: multifaceted approach to decontamination of a water system. Infect Control Hosp Epidemiol (1993) 1.44
Purification and properties of L cell-derived colony-stimulating factor. J Lab Clin Med (1979) 1.41
alpha-Interferon in myelofibrosis: a case report. Br J Haematol (1994) 1.40
Amino-terminal amino acid sequence of murine colony-stimulating factor 1. Proc Natl Acad Sci U S A (1985) 1.27
Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol (1985) 1.20
Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. Proc Natl Acad Sci U S A (1987) 1.18
Effect of Listeria monocytogenes infection on serum levels of colony-stimulating factor and number of progenitor cells in immune and nonimmune mice. Infect Immun (1985) 1.15
Granulocyte colony stimulating factor. I. Response to acute granulocytopenia. Blood (1971) 1.14
Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14
Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J Cell Physiol (1992) 1.13
Fractionation of antibodies to L-cell colony-stimulating factor by affinity chromatography. Blood (1979) 1.12
Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity. J Clin Invest (1982) 1.12
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int (1984) 1.11
Stimulatory effects of purified macrophage colony-stimulating factor on murine resident peritoneal macrophages. Cell Immunol (1986) 1.09
Hematopoietic factor production by a cell line (TC-1) derived from adherent murine marrow cells. Blood (1985) 1.06
Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosus: reversal with corticosteroid therapy. Am J Hematol (1978) 1.05
Aplastic anemia following infectious mononucleosis: possible immune etiology. Exp Hematol (1979) 1.04
Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol (2001) 1.04
Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series) derived from murine epidermis. J Immunol (1995) 1.02
Murine bone marrow cell line producing colony-stimulating factor. Proc Natl Acad Sci U S A (1981) 1.02
Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions. Blood (1989) 1.00
Preparation and neutralization characteristics of an anti-CSF antibody. J Cell Physiol (1975) 1.00
Cellular origin of granulocyte colonies in chronic myeloid leukaemia. Lancet (1971) 0.97
Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease. Bone Marrow Transplant (1991) 0.96
Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 0.96
Purification of colony-stimulating factor by affinity chromatography. Blood (1982) 0.95
CNS involvement as the initial manifestation of acute leukemia. Cancer (1973) 0.95
Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. Cancer Chemother Rep (1967) 0.93
Observations on the anemia and neutropenia of human copper deficiency. Am J Hematol (1977) 0.92
The effect of preirradiation of recipient mice on the proliferation of transplanted hemopoietic stem cells. Blood (1971) 0.92
A method for the removal of endotoxin from purified colony-stimulating factor. Proc Soc Exp Biol Med (1980) 0.91
Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apher (2001) 0.90
Cytokine expression from bone marrow derived macrophages. Exp Hematol (1993) 0.89
The kinetics of cyclosporine and its metabolites in bone marrow transplant patients. Br J Clin Pharmacol (1991) 0.89
Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease. J Lab Clin Med (1985) 0.88
High-dose intravenous gamma globulin improves responses to single-donor platelets in patients refractory to platelet transfusion. Blood (1987) 0.88
Production of colony stimulating factor in long-term bone marrow cultures. J Cell Physiol (1983) 0.88
Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J Immunol (1992) 0.87
Hematopoietic regulatory factors produced in long-term murine bone marrow cultures and the effect of in vitro irradiation. Blood (1984) 0.87
Hairy cell leukaemia: seven cases with probable B-lymphocytic origin. Br J Haematol (1977) 0.87
Physiologic distribution of colony-stimulating factor in vivo. Blood (1979) 0.87
Ex vivo expansion of human umbilical cord blood and peripheral blood CD34(+) hematopoietic stem cells. Exp Hematol (2000) 0.86
Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. Exp Hematol (1987) 0.86
The regulation of haemopoiesis in long-term bone marrow cultures: I. role of L-cell CSF. J Cell Physiol (1980) 0.86
The role of colony-stimulating factor in granulopoiesis. J Supramol Struct (1980) 0.86
Demonstration of two distinct antibodies in autoimmune hemolytic anemia with reticulocytopenia and red cell aplasia. Exp Hematol (1984) 0.86
Colony-stimulating activity in cultures of granulocytosis-inducing tumor. Proc Soc Exp Biol Med (1977) 0.86
Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice. Cancer Res (1981) 0.86
Macrophage colony-stimulating factor enhances the expression of Fc receptors on murine peritoneal macrophages. Immunology (1987) 0.86
Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. Am J Hematol (1998) 0.85
Peritoneal macrophages exposed to purified macrophage colony-stimulating factor (M-CSF) suppress mitogen- and antigen-stimulated lymphocyte proliferation. J Immunol (1986) 0.85
Binding of colony stimulating factor by sterile filtration membranes. Exp Hematol (1978) 0.85
Granulocyte colony stimulating factor. 3. Effect of alkylating agent induced granulocytopenia. Proc Soc Exp Biol Med (1971) 0.84
Observations on the binding and interaction of radioiodinated colony-stimulating factor with murine bone marrow cells in vivo. Blood (1982) 0.83
Acute myelobalstic leukemia and hypercalcemia. A case of probable ectopic parathyroid hormone production. N Engl J Med (1976) 0.82
The effect of recombinant human granulocyte macrophage colony-stimulating factor on neutrophil activation in patients with refractory carcinoma. Blood (1989) 0.82
A differential effect of hydroxyurea on hemopoietic stem cell colonies in vitro and in vivo. Proc Soc Exp Biol Med (1970) 0.82
Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood (1989) 0.82
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood (1994) 0.82
Interferon-induced aplasia: evidence for T-cell-mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin. Am J Hematol (1985) 0.81
Disposition of total and unbound etoposide following high-dose therapy. Cancer Chemother Pharmacol (1993) 0.81
Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol (1995) 0.81
The influence in vivo of murine colony-stimulating factor-1 on myeloid progenitor cells in mice recovering from sublethal dosages of cyclophosphamide. Blood (1987) 0.81
Identification of the hematopoietic growth factors elaborated by bone marrow stromal cells using antibody neutralization analysis. Exp Hematol (1987) 0.81
Initial toxicity study of sangivamycin (NSC-65346). Cancer Chemother Rep (1967) 0.80
Persistent production of colony-stimulating factor (CSF-1) by cloned bone marrow stromal cell line D2XRII after X-irradiation. J Cell Physiol (1986) 0.80
CSF response to endotoxin in normal and leukopenic recipients. Exp Hematol (1974) 0.80
Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura. Blood (1993) 0.79
Myeloid stem cell kinetics during erythropoietic stress. Br J Haematol (1971) 0.79
Clinical toxicologic study of cyclohexylamine salt of N,N-bis(2-chlorethyl)phosphorodiamidic acid (NSC-69945; OMF-59). Cancer Chemother Rep (1967) 0.79
Identification of a growth factor for primary murine stroma as macrophage colony-stimulating factor. Blood (1995) 0.79
Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia. Leuk Lymphoma (2003) 0.79
Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange. Transfusion (1982) 0.78
Ex vivo purging of allogeneic marrow with L-Leucyl-L-leucine methyl ester. A phase I study. Transplantation (1995) 0.78
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Blood (1989) 0.78
Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow cultures. Blood (1987) 0.78
Heterogeneity of murine mammary adenocarcinoma cell subpopulations. In vitro and in vivo resistance to macrophage cytotoxicity and its association with metastatic capacity. Int J Cancer (1984) 0.78
Perforation of an unsuspected cecal granulocytic sarcoma during therapy with granulocyte-macrophage colony-stimulating factor. N Engl J Med (1990) 0.78
Identification of hemopoietic cells responsive to colony-stimulating factor by autoradiography. Blood (1983) 0.78
The effects of interleukins and other soluble factors on T-lymphocyte colony formation. Immunology (1986) 0.78
Complications of indwelling central venous catheters in bone marrow transplant recipients. Surg Gynecol Obstet (1991) 0.78
Effects of low dose rate irradiation on plateau phase bone marrow stromal cells in vitro: demonstration of a new form of non-lethal, physiologic damage to support of hematopoietic stem cells. Int J Radiat Oncol Biol Phys (1984) 0.78
Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura. Am J Hematol (1993) 0.78
UVB radiation interrupts cytokine-mediated support of an epidermal-derived dendritic cell line (XS52) by a dual mechanism. J Invest Dermatol (1996) 0.78
Thrombotic thrombocytopenic purpura: clinical course and response to therapy in eight patients. Am J Hematol (1984) 0.77
Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant (1995) 0.77